Related references
Note: Only part of the references are listed.Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in US Hospitals during 2016 to 2018
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureus
Razieh Kebriaei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
Corrado Campochiaro et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of InvasiveKlebsiella pneumoniaein a Multi-Country Collection
Myeongjin Choi et al.
FRONTIERS IN MICROBIOLOGY (2020)
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis
Vance G. Fowler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Investigating Bacteriophages Targeting the Opportunistic Pathogen Acinetobacter baumannii
Kathryn M. Styles et al.
ANTIBIOTICS-BASEL (2020)
Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens
Daniel V. Zurawski et al.
ANTIBIOTICS-BASEL (2020)
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect
Paul G. Ambrose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers
Melicent Peck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kaitlyn E. Kortright et al.
CELL HOST & MICROBE (2019)
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial
Pierre-Francois Laterre et al.
LANCET INFECTIOUS DISEASES (2019)
Re-estimating annual deaths due to multidrug-resistant organism infections
Jason P. Burnham et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)
Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity
Paul G. Ambrose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
Bruno Francois et al.
INTENSIVE CARE MEDICINE (2018)
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Luca Falzone et al.
FRONTIERS IN PHARMACOLOGY (2018)
Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia
Shankaramurthy Channabasappa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself
Paul G. Ambrose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages
Agata Anna Cisek et al.
CURRENT MICROBIOLOGY (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258
Valeria Szijarto et al.
VIRULENCE (2017)
Antibacterial monoclonal antibodies: the next generation?
Antonio DiGiandomenico et al.
CURRENT OPINION IN MICROBIOLOGY (2015)
Repairing The Broken Market For Antibiotic Innovation
Kevin Outterson et al.
HEALTH AFFAIRS (2015)
Monoclonal antibodies for the treatment of cancer
Casey W. Shuptrine et al.
SEMINARS IN CANCER BIOLOGY (2012)
Fighting bacterial infections-Future treatment options
Jenny Fernebro
DRUG RESISTANCE UPDATES (2011)
Antivirulence drugs to target bacterial secretion systems
Christian Baron
CURRENT OPINION IN MICROBIOLOGY (2010)
Phage Choice, Isolation, and Preparation for Phage Therapy
Jason J. Gill et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Mzia Kutateladze et al.
TRENDS IN BIOTECHNOLOGY (2010)
Share Paper
